References
- Haïssaguerre
M,
Shah
DC,
Jaïs
P et al. Electrophysiological breakthroughs from the left atrium to
the pulmonary veins. Circulation 2000;102:2463-2465.
- Nault
I,
Miyazaki
S,
Forclaz
A et al. Drugs vs. ablation for the treatment of atrial fibrillation:
the evidence supporting catheter ablation.
Eur
Heart J. 2010;31:1046-1054.
- Calkins
H,
Kuck
KH,
Cappato
R et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter
and surgical ablation of atrial fibrillation: recommendations for
patient selection, procedural techniques, patient management and
follow-up, definitions, endpoints, and research trial design: a report
of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical
Ablation of Atrial Fibrillation.
Heart
Rhythm. 2012;9:632-696.
- Haïssaguerre
M,
Jaïs
P,
Shah
DC et al. Spontaneous initiation of atrial fibrillation by ectopic
beats originating in the pulmonary veins.
N
Engl J Med. 1998;339:659-666.
- Parkash
R,
Tang
AS,
Sapp
JL,
Wells
G. Approach to the catheter ablation technique of paroxysmal and
persistent atrial fibrillation: a meta-analysis of the randomized
controlled trials.
J
Cardiovasc Electrophysiol. 2011;22:729-738.
- Pappone
C,
Augello
G,
Sala
S et al. A randomized trial of circumferential pulmonary vein
ablation versus antiarrhythmic drug therapy in paroxysmal atrial
fibrillation: the APAF Study.
J
Am Coll Cardiol. 2006;48:2340-2347.
- Calkins
H,
Reynolds
MR,
Spector
P et al. Treatment of atrial fibrillation with antiarrhythmic drugs
or radiofrequency ablation: two systematic literature reviews and
meta-analyses.
Circ
Arrhythm Electrophysiol. 2009;2:349-361.
- Tang
RB,
Dong
JZ,
Liu
XP et al. Obstructive sleep apnoea risk profile and the risk of
recurrence of atrial fibrillation after catheter ablation.
Europace.
2009;11:100-105.
- D’Ascenzo
F,
Corleto
A,
Biondi-Zoccai
G et al. Which are the most reliable predictors of recurrence of
atrial fibrillation after transcatheter ablation?: a meta-analysis.
Int
J Cardiol. 2013;167:1984-1989.
- Zhuang
J,
Wang
Y,
Tang
K et al. Association between left atrial size and atrial fibrillation
recurrence after single circumferential pulmonary vein isolation: a
systematic review and meta-analysis of observational studies.
Europace.
2012;14:638-645.
- Koyama
T,
Sekiguchi
Y,
Tada
H et al. Comparison of characteristics and significance of immediate
versus early versus no recurrence of atrial fibrillation after
catheter ablation.
Am
J Cardiol. 2009;103:1249-54.
- Lim
HS,
Schultz
C,
Dang
J et al. Time course of inflammation, myocardial injury, and
prothrombotic response after radiofrequency catheter ablation for
atrial fibrillation.
Circ
Arrhythm Electrophysiol. 2014;7:83-89.
- Andrade
JG,
Khairy
P,
Verma
A et al. Early recurrence of atrial tachyarrhythmias following
radiofrequency catheter ablation of atrial fibrillation.
Pacing
Clin Electrophysiol. 2012;35:106-116.
- Richter
B,
Gwechenberger
M,
Socas
A,
Marx
M,
Gössinger
HD. Frequency of recurrence of atrial fibrillation within 48 hours
after ablation and its impact on long-term outcome.
Am
J Cardiol. 2008;101:843-847.
- Ijsselmuiden
AJ,
Musters
RJ,
de
Ruiter G et al. Circulating white blood cells and platelets amplify
oxidative stress in heart failure.
Nat
Clin Pract Cardiovasc Med. 2008;5:811-820.
- Panni
RZ,
Lopez-Aguiar
AG,
Liu
J et al. Association of preoperative monocyte-to-lymphocyte and
neutrophil-to-lymphocyte ratio with recurrence-free and overall
survival after resection of pancreatic neuroendocrine tumors
(US-NETSG).
J
Surg Oncol. 2019;120:632-638.
- Afari
ME,
Bhat
T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases:
an update.
Expert
Rev Cardiovasc Ther. 2016;14:573-577.
- Kumagai
K,
Tojo
H,
Noguchi
H et al. Effects of the NA+ channel blocker pilsicainide on the
electrophysiologic properties of pulmonary veins in patients with
atrial fibrillation.
J Cardiovasc
Electrophysiol. 2004;15:1396-1401.
- Lellouche
N,
Sacher
F,
Wright
M Usefulness of C-reactive protein in predicting early and late
recurrences after atrial fibrillation ablation.
Europace.
2009;11:662-664.
- Katritsis
D,
Hossein-Nia
M,
Anastasakis
A et al. Use of troponin-T concentration and kinase isoforms for
quantitation of myocardial injury induced by radiofrequency catheter
ablation.
Eur
Heart J. 1997;18:1007-1013.
- Summers
C,
Rankin
SM,
Condliffe
AM,
Singh
N,
Peters
AM,
Chilvers
ER. Neutrophil kinetics in health and disease.
Trends
Immunol. 2010;31:318-324.
- Zhan
Y,
Lieschke
GJ,
Grail
D,
Dunn
AR,
Cheers
C. Essential roles for granulocyte-macrophage colony-stimulating
factor (GM-CSF) and G-CSF in the sustained hematopoietic response of
Listeria monocytogenes-infected mice.
Blood.
1998;91:863-869.
- Li
X,
Ji
Y,
Kang
J et al. Association between blood neutrophil-to-lymphocyte ratio and
severity of coronary artery disease: Evidence from 17 observational
studies involving 7017 cases.
Medicine
(Baltimore). 2018;97:e12432.
- Diakos
CI,
Charles
KA,
McMillan
DC,
Clarke
SJ. Cancer-related inflammation and treatment effectiveness.
Lancet
Oncol. 2014;15:e493-503.
- Gravani
F,
Papadaki
I,
Antypa
E et al. Subclinical atherosclerosis and impaired bone health in
patients with primary Sjogren’s syndrome: prevalence, clinical and
laboratory associations.
Arthritis Res
Ther. 2015;17:99.
- Lin
J,
Zhang
W,
Huang
Y et al. Sarcopenia is associated with the neutrophil/lymphocyte and
platelet/lymphocyte ratios in operable gastric cancer patients: a
prospective study.
Cancer
Manag Res. 2018;10:4935-4944.
- Nam
KW,
Kwon
HM,
Jeong
HY,
Park
JH,
Kim
SH,
Jeong
SM. High neutrophil to lymphocyte ratios predict intracranial
atherosclerosis in a healthy population.
Atherosclerosis.
2018;269:117-121.
- Suades R, Padro T, Vilahur G et al. Circulating and platelet-derived
microparticles in human blood enhance thrombosis on atherosclerotic
plaques. Thromb Haemost 2012;108:1208–1219.
- Kwon HC, Kim SH, Oh SY et al. Clinical significance of preoperative
neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients
with operable colorectal cancer. Biomarkers 2012;17:216–222.
- Gary
T,
Pichler
M,
Belaj
K et al. Platelet-to-lymphocyte ratio: a novel marker for critical
limb ischemia in peripheral arterial occlusive disease patients.
PLoS
One. 2013;8:e67688
- Qin
B,
Ma
N,
Tang
Q et al. Neutrophil to lymphocyte ratio (NLR) and platelet to
lymphocyte ratio (PLR) were useful markers in assessment of
inflammatory response and disease activity in SLE patients.
Mod
Rheumatol. 2016;26:372-376.
- Issac
TT,
Dokainish
H,
Lakkis
NM. Role of inflammation in initiation and perpetuation of atrial
fibrillation: a systematic review of the published data.
J
Am Coll Cardiol. 2007;50:2021-2028.
- Aviles
RJ,
Martin
DO,
Apperson-Hansen
C et al. Inflammation as a risk factor for atrial fibrillation.
Circulation.
2003;108:3006-10.
- Das
M,
Wynn
GJ,
Morgan
M et al. Recurrence of atrial tachyarrhythmia during the second month
of the blanking period is associated with more extensive pulmonary
vein reconnection at repeat electrophysiology study.
Circ Arrhythm
Electrophysiol. 2015;8:846-52.
- Mujović
N,
Marinković
M,
Marković
N et al. The relationship of early recurrence of atrial fibrillation
and the 3-month integrity of the ablation lesion set.
Sci Rep.
2018;8:9875.